ArticleBlood cancer journal2022

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).

Warren Fiskus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.